Cardiac failure. Heart failure
Conditions
Interventions
Intervention 1: The intervention group receives Thiamine as 200 mg bolus dose during 30 minutes followed by 50 mg/hr to 24 hours. Intervention 2: The control group receives normal saline as the placeb
Treatment - Drugs
Placebo
The intervention group receives Thiamine as 200 mg bolus dose during 30 minutes followed by 50 mg/hr to 24 hours.
The control group receives normal saline as the placebo similar to Thiamine administration in intervention group.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria :CABG candidates; ejection fraction>40%; age >18 years old. Exclusion criteria: emergency operation; accompanying surgery; history of recent alcohol abuse; EF>40%; recent consumption of group B vitamins and Cefteriaxone; off pump CABG; sensitivity to group B vitamins .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood lactate level. Timepoint: 0, 6, 18, and 24 hours after intervention. Method of measurement: Bloos sample lab test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intubation time. Timepoint: During hospitalization. Method of measurement: clinical assessment.;Duration of hospitalization. Timepoint: During hospitalization. Method of measurement: Clinical Assessment.;Length of stay in ICU. Timepoint: During hospitalization. Method of measurement: Clinical Assessment.;One-month mortality. Timepoint: 1 mo after ICU admision. Method of measurement: Clinical Assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Khosro Barkhordari
Tehran Heart Center hospital
Outcome results
None listed